Citicoline (sodium salt)

Citicoline (sodium salt) (CAS No.: 33818-15-4) is a biologically relevant intermediate in the biosynthesis of phosphatidylcholine, a principal phospholipid of eukaryotic cell membranes, and serves as a choline donor for acetylcholine production, positioning it as a key molecule in neurochemical and membrane homeostasis research. Functionally, it exhibits neuroprotective properties by modulating membrane repair processes, enhancing phospholipid synthesis, and attenuating oxidative stress through inhibition of reactive oxygen species generation and apoptosis-related pathways. It has also been shown to influence lipid signaling dynamics, including reductions in arachidonic acid release and ceramide accumulation, which are implicated in cellular injury responses. Citicoline sodium is widely employed in studies of neurological disorders, including cerebral ischemia, traumatic brain injury, neurodegeneration, and sensory dysfunction such as hearing loss, as well as in investigations of neuronal survival, synaptic function, and membrane integrity. In vitro and in vivo experimental applications typically explore its activity across low micromolar to millimolar concentration ranges depending on the model system, with dosing regimens in animal studies tailored to specific injury paradigms and research objectives. Its broad utility in cell biology, pharmacology, and drug discovery makes it a valuable tool for elucidating mechanisms of neuroprotection and membrane-associated signaling.